Further biosimilar competition to Avastin (bevacizumab) is looming in Europe after Stada and Mabxience received positive opinions recommending granting pan-European marketing authorizations for th
Byfavo (remimazolam), Paion’s drug for procedural sedation, and Ontozry (cenobamate), Arvelle Therapeutics’ epilepsy treatment, are among the 13 new drugs that the European Medicines Agency has said s
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Bayer/Evotec Collaboration O
Financings During the third quarter of 2012, biopharma financings jumped to just over $3 billion, a 13% increase over the Q2 total. Heading the list was small-molecule cancer therapeutics developer